Opportunity for Evaluation of Selected Medicines - Covid-19 Pharmaceutical Products
The Global Fund is inviting manufacturers of COVID-19 pharmaceutical products (namely Molnupiravir 200mg capsules for oral administration) to submit an expression of interest to have their product evaluated by the Expert Review Panel for Pharmaceutical Products.
Source: theglobalfund.org